Cimetidine as an organic cation transporter antagonist

American Journal of Pathology

Volumn 177, Issue 3, 2010, Pages 1573-1574

  Ehrsson, Hans ^a   Wallin, Inger ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CIMETIDINE; CISPLATIN; METHIONINE; ORGANIC CATION TRANSPORTER 2; OXALIPLATIN;

DRUG EFFECT; DRUG MECHANISM; EAR PROTECTION; LETTER; NONHUMAN; OTOTOXICITY; PRIORITY JOURNAL;

EID: 77956516625     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.2353/ajpath.2010.100484     Document Type: Letter

References (12)

1. Ciarimboli G, Deuster D, Knief A, Sperling M, Holtkamp M, Edemir B, Pavenstädt H, Lanvers-Kaminsky C, Zehnhoff-Dinnesen A, Schinke AH, Koepsell H, Jürgens H, Schlatter E: Organic cation transporter 2 mediates cisplatin-induced oto- and nephrotoxicity and is a target for protective interventions. Am J Pathol 2010, 176:1-12
2. Corden BJ: Reaction of platinum(II) antitumor agents with sulfhydral compounds and the implications for nephrotoxicity. Inorg Chim Acta 1987, 137:125-130
3. El-Khateeb M, Appleton TG, Gahan LR, Charles BG, Berners-Price SJ, Bolton A-M: Reactions of cisplatin hydrolytes with methionine, cystein, and plasma ultrafiltrate studied by a combination of HPLC and NMR techniques. J Inorg Biochem 1999, 77:13-21 (Pubitemid 30089076)
4. Dabrowiak JC, Goodisman J, Souid A-K: Kinetic study of the reaction of cisplatin with thiols. Drug Metab Disp 2002, 30:1378-1384 (Pubitemid 35397042)
5. Verschraagen M, Kedde MA, Hausheer FH, van der Vijgh WJF: The chemical reactivity of BNP7787 and its metabolite mesna with the cytostatic agent cisplatin: comparison with the nucleophiles thiosulfate, DDTC, glutathione and its disulphide GSSG. Cancer Chemother Pharmacol 2003, 51:499-504 (Pubitemid 36791676)
6. Videhult P, Laurell G, Wallin I, Ehrsson H: Kinetics of cisplatin and its monohydrated complex with sulphur-containing compounds designed for local otoprotective administration. Exp Biol Med 2006, 231:1638-1645 (Pubitemid 44808368)
7. Jerremalm E, Wallin I, Yachnin J, Ehrsson H: Oxaliplatin degradation in the presence of important biological sulphur-containing compounds and plasma ultrafiltrate. Eur J Pharm Sci 2006, 28:278-283 (Pubitemid 43776197)
8. Buss I, Kalayda GV, Marques-Gallego P, Reedijk J, Jaehde U: Influence of the hOCT2 inhibitor cimetidine on the cellular accumulation and cytotoxicity of oxaliplatin. Int J Clin Pharmacol Ther 2009, 47:51-54
9. Ekborn A, Laurell G, Johnström P, Wallin I, Eksborg S, Ehrsson H: D-Methionine and cisplatin ototoxicity in the guinea pig: D-methionine influences cisplatin pharmacokinetics. Hear Res 2002, 165:53-61
10. Hellberg V, Wallin I, Eriksson S, Hernlund E, Jerremalm E, Berndtsson M, Eksborg S, Arnér ESJ, Shoshan M, Ehrsson H, Laurell G: Cisplatin and oxaliplatin toxicity: importance of cochlear kinetics as a determinant for ototoxicity. J Natl Cancer Inst 2009, 101:37-47
11. Ekborn A, Lindberg A, Laurell G, Wallin I, Eksborg S, Ehrsson H: Ototoxicity, nephrotoxicity and pharmacokinetics of cisplatin and its monohydrated complex in the guinea pig. Cancer Chemother Pharmacol 2003, 51:36-42
12. Suhre WM, Ekins S, Chang C, Swaan PW, Wright SH: Molecular determinants of substrate/inhibitor binding to the human and rabbit renal organic cation transporters hOCT2 and rbOCT2. Mol Pharmacol 2005, 67:1067-1077 (Pubitemid 40410407)